Cardiovascular disease is one of the most common causes of death in Sweden and in the world. Researchers at Karolinska Institutet in Sweden, among others, have now found that artificial intelligence seems to play a role in identifying the risk of cardiovascular disease.
Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership
Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.